Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Donor-derived cell-free DNA is a valuable monitoring tool after single lung transplantation: Multicenter analysis

28 Aug 2024

Abstract excerpt

Background Donor-derived cell-free DNA (dd-cfDNA) is a nonspecific plasma biomarker for tissue injury that has been validated for monitoring acute rejection (AR) after lung transplantation (LT). However, no studies to date have focused specifically on single lung transplantation (SLT). Herein, we report the performance of dd-cfDNA in detecting AR in SLT from 6 academic centers that implemented this biomarker...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Organ Transplantation Techniques and Outcomes
Share to Renal Transplantation Outcomes and Treatments
Share to Transplantation: Methods and Outcomes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40145054
DOI: 10.1016/j.jhlto.2024.100155

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Donor-derived cell-free DNA is a valuable monitoring tool after single lung transplantation: Multicenter analysisPMID 40145054Read ↗

Why Cell-Free DNA Can Be a “Game Changer” for Lung Allograft Monitoring for Rejection and InfectionSemantic proximity Read ↗

Nuances in the interpretation and utility of donor-derived cell-free DNA in lung transplantation following allogeneic hematopoietic stem cell transplantation - Case report.Semantic proximity Read ↗

Graft-derived Cell-free DNA as a Noninvasive Biomarker of Cardiac Allograft Rejection: A Cohort Study on Clinical Validity and Confounding FactorsSemantic proximity Read ↗

A two-threshold algorithm using donor-derived cell-free DNA fraction and quantity to detect acute rejection after heart transplantationSemantic proximity Read ↗

Comparison of methods for donor-derived cell-free DNA quantification in plasma and urine from solid organ transplant recipientsSemantic proximity Read ↗

Noninvasive monitoring of infection and rejection after lung transplantation.Semantic proximity Read ↗

Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantationSemantic proximity Read ↗

Donor derived cell free DNA in lung transplant recipients rises in setting of allograft instabilitySemantic proximity Read ↗

Cell‐free DNA as a biomarker after lung transplantation: A proof‐of‐concept studySemantic proximity Read ↗

Multi‐centre analytical performance verification of an IVD assay to quantify donor‐derived cell‐free DNA in solid organ transplant recipientsSemantic proximity Read ↗

Validation of a Clinical-Grade Assay to Measure Donor-Derived Cell-Free DNA in Solid Organ Transplant Recipients.Semantic proximity Read ↗

Comparison of Methods for Donor-Derived Cell-Free DNA Quantification in Plasma and Urine from Solid Organ Transplant RecipientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.